Zirconium organomagnesium compounds

Less acidic than Ti and Zi chloroderivatives, MeTi(OPr )3 perfoims chelation-controlled addition to chiral alkoxy ketones as well as or better than organomagnesium compounds, but fails to chelate to aldehydes or hindered ketones. Should the formation of a cyclic chelation intermediate be forbidden, the reaction is subject to nonchelation control, according to Ae Felkin-Anh (or Comforth) model. Under these circumstances, the ratio of the diastereomeric products is inverted in favor of the anti-Cram product(s). In the case of benzil (83 Scheme 7) this can be accounted for by the unlikely formation of a cyclic intermediate such as (85), and thus the preferential intermediacy of the open chain intermediate (86) that leads to the threo compound (88). This view is substantiated by the fact that replacement of titanium with zirconium, which is characterized by longer M—O bonds, restores the possibility of having a cyclic intermediate and, as a consequence, leads to the erythro meso) compound (87) thus paralleling the action of Mg and Li complexes. 

Synthesis of l-chloro-2,8,9-carbagermatrane (221) by trans-metallation reaction of trial-lylamine and GeCLt in the presence of zirconium compounds (equation 59) was reported recently632. Subsequent reactions with organomagnesium or organolithium derivatives lead to l-organyl-2,8,9-carbagermatranes (222) (e.g. R = Bu, Ph, Vin, All). 

---